
A Harris Poll finds Americans want a US-approved COVID-19 vaccine allocated here first, the rest of the world next, and our most vulnerable take priority.

A Harris Poll finds Americans want a US-approved COVID-19 vaccine allocated here first, the rest of the world next, and our most vulnerable take priority.

The FDA issued an emergency use authorization for convalescent plasma for the treatment of COVID-19 in hospitalized patients.

VIDEO: NIH-funded infectious disease expert discusses convalescent plasma, remdesivir, corticosteroids, and the COVID-19 vaccine timeline.

Groups at high risk for influenza and its complications were less likely to receive vaccination while hospitalized vs the general population, according to a new study.

The COVID-19 pandemic makes timely catch-up vaccination against all vaccine-preventable diseases essential. Try these 5 questions on CDC recommendations.

Patients with severe obesity are 4-times as likely to die from COVID-19, a new study finds, with younger patients and men with obesity at highest risk.

Pneumococcal vaccine should still be given to adults aged ≥65 years, but no longer to all adults in that population. Find out what you know - and what you may need to know.

The ACIP, once more, revised its recommendations for administration of pneumococcal vaccination among adults aged ≥65 years. Is there a lesson learned here?

HCV is now diagnosed in millennials at about the same rate as in baby boomers; CDC responds with a recommendation for HCV screening in all adults aged ≥18 years.

A pulmonary and critical care specialist identifies 4 factors that will, in part, determine the severity of the 2020-2021 flu season and that can inform preparation.

The investigational antiviral remdesivir in phase 3 clinical trials led to faster time to recovery vs placebo and was found to be safe.

There are nearly 30 COVID-19 vaccine candidates in human trials. Confused? Here's a short primer on the old and new development platforms and the pros and cons.

US confirmed cases of COVID-19 surpassed 5 million; global recoveries have exceeded 12 million. We summarize more of today's data from the Johns Hopkins COVID-19 interactive map.

Communicating the importance of immunization to wary patients is key during the COVID-19 pandemic. Check out our new slideshow for the most recent CDC guidance for clinicians.

Data from the Johns Hopkins COVID-19 interactive map on coronavirus cases, mortalities, recoveries, and more.

Data from the Johns Hopkins COVID-19 interactive map on coronavirus cases, mortalities, recoveries, and more.

US confirmed cases of COVID-19 number nearly 4.6 million; global cases have surpassed 18 million. We summarize more of today's data from the Johns Hopkins COVID-19 interactive map.

The National Institutes of Health updated guidance on use of dexamethasone and substitutes in critically ill patients, and on ensuring surrogate decision makers are identified.

US confirmed cases of COVID-19 number nearly 4.5 million; global cases have surpassed 17 million. We summarize more of today's data from the Johns Hopkins COVID-19 interactive map.

Flu vaccination coverage for adults is highest in West Virginia, lowest in Louisiana. Where does your state rank on flu, HPV, pneumococcal and 5 other vaccines?

US confirmed cases of COVID-19 number nearly 4.5 million; global cases have surpassed 17 million. We summarize more of today's data from the Johns Hopkins COVID-19 interactive map.

A trio of experts will discuss the prospects of a handful of COVID-19 vaccine candidates which are entering phase 3 trials.

Global confirmed cases of COVID-19 are approaching 16.5 million. We summarize more of today's global and US data from the Johns Hopkins COVID-19 interactive map.

COVID-19 vaccine hopeful mRNA-1273 will be administered to 30,000 trial volunteers at 89 US research sites.

Global confirmed cases of COVID-19 have surpassed 16 million. We summarize more of today's global and US data from the Johns Hopkins COVID-19 interactive map.